When BCL2L2 expression was inhibited by miR‐335‐5p, the DDP resistance of ovarian cancer cells was significantly alleviated, resulting in an accelerating cell apoptosis and cell cycle arrest at G1 phase. Here, BCL2L2 is linked to ovarian carcinoma.